UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 343

Sortiert nach

Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias

Leukemia, 2011-07, Vol.25 (7), p.1147-1152

2011

Link zum Volltext

Verfügbarkeit prüfen

Targeting MYC in multiple myeloma

Leukemia, 2018-06, Vol.32 (6), p.1295-1306

2018

Link zum Volltext

Verfügbarkeit prüfen

Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms

Leukemia, 2010-05, Vol.24 (5), p.1094-1096

2010

Link zum Volltext

Verfügbarkeit prüfen

RIP3 is downregulated in human myeloid leukemia cells and modulates apoptosis and caspase-mediated p65/RelA cleavage

Cell death & disease, 2014-08, Vol.5 (8), p.e1384-e1384

2014

Link zum Volltext

Verfügbarkeit prüfen

Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML)

Leukemia, 2006-06, Vol.20 (6), p.965-970

2006

Link zum Volltext

Verfügbarkeit prüfen

Copy-number analysis identified new prognostic marker in acute myeloid leukemia

Leukemia, 2017-03, Vol.31 (3), p.555-564

2017

Link zum Volltext

Verfügbarkeit prüfen

Impact of Wilms' tumor 1 expression on outcome of patients undergoing allogeneic stem cell transplantation for AML

Bone marrow transplantation (Basingstoke), 2017-04, Vol.52 (4), p.539-543

2017

Link zum Volltext

Verfügbarkeit prüfen

GATA2 gene mutations: 3 cases

La revue de medecine interne, 2022-11, Vol.43 (11), p.677-682

2022

Link zum Volltext

Verfügbarkeit prüfen

Thoracic air bubbles of unusual cause

La revue de medecine interne, 2020-10, Vol.41 (10), p.714-715

2020

Link zum Volltext

Verfügbarkeit prüfen

GILZ inhibits the mTORC2 AKT pathway in BCR-ABL cells

Oncogene, 2012-03, Vol.31 (11), p.1419-1430

2012

Link zum Volltext

Verfügbarkeit prüfen

Molecular prognostic factors in acute myeloid leukemia receiving first-line therapy with azacitidine

Leukemia, 2016-06, Vol.30 (6), p.1416-1418

2016

Link zum Volltext

Verfügbarkeit prüfen

Shortened First-Line High-Dose Chemotherapy for Patients With Poor-Prognosis Aggressive Lymphoma

Journal of clinical oncology, 2002-05, Vol.20 (10), p.2472-2479

2002

Link zum Volltext

Verfügbarkeit prüfen

Prognostic significance of monosomal karyotype in higher risk myelodysplastic syndrome treated with azacitidine

Leukemia, 2011-07, Vol.25 (7), p.1207-1209

2011

Link zum Volltext

Verfügbarkeit prüfen

P851: TARGETING GENE DEPENDENCIES IN MYC OVEREXPRESSING MULTIPLE MYELOMA

HemaSphere, 2022-06, Vol.6 (Suppl), p.745-746

2022

Link zum Volltext

Verfügbarkeit prüfen

Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy

Leukemia, 2006-01, Vol.20 (1), p.35-41

2006

Link zum Volltext

Verfügbarkeit prüfen

Long-term follow up of invasive aspergillosis in allogeneic stem cell transplantation recipients and leukemia patients: Differences in risk factors and outcomes

Current research in translational medicine, 2017-04, Vol.65 (2), p.77-81

2017

Link zum Volltext

Verfügbarkeit prüfen

P1257: MOLECULAR CHARACTERIZATION AND CLONAL EVOLUTION OF MYCOSIS FUNGOIDES

HemaSphere, 2022-06, Vol.6 (Suppl), p.1142-1143

2022

Link zum Volltext

Verfügbarkeit prüfen

BCR-ABL mutants spread resistance to non-mutated cells through a paracrine mechanism

Leukemia, 2008-04, Vol.22 (4), p.791-799

2008

Link zum Volltext

Verfügbarkeit prüfen

5LBA Results of a first-in-man phase I trial assessing OTX015, an orally available BET-bromodomain (BRD) inhibitor, in advanced hematologic malignancies

European journal of cancer (1990), 2014-11, Vol.50, p.196-196

2014

Link zum Volltext

Verfügbarkeit prüfen

Effect of priming with granulocyte-macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group

Leukemia, 2007-03, Vol.21 (3), p.453-461

2007

Link zum Volltext

Verfügbarkeit prüfen

High occurrence of JAK2 V617 mutation in refractory anemia with ringed sideroblasts associated with marked thrombocytosis

Leukemia, 2006-11, Vol.20 (11), p.2067-2070

2006

Link zum Volltext

Verfügbarkeit prüfen

PO-264 Mitochondrial metabolism: a key factor of myeloid leukemic cell response upon exposure to tyrosine kinase inhibitors

ESMO open, 2018-07, Vol.3 (Suppl 2), p.A123-A124

2018

Link zum Volltext

Verfügbarkeit prüfen

Successful treatment of imatinib-resistant acute megakaryoblastic leukemia with e6a2 BCR ABL: use of dasatinib and reduced-conditioning stem-cell transplantation

Leukemia, 2007-11, Vol.21 (11), p.2376-2377

2007

Link zum Volltext

Verfügbarkeit prüfen

Molecular characterization of the idiopathic hypereosinophilic syndrome (HES) in 35 French patients with normal conventional cytogenetics

Leukemia, 2005-05, Vol.19 (5), p.792-798

2005

Link zum Volltext

Verfügbarkeit prüfen

Comment on “Experimental Observation of Electrons Accelerated in Vacuum to Relativistic Energies by a High-Intensity Laser”

Physical review letters, 1998-02, Vol.80 (6), p.1351-1351

1998

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 343

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(295)
Mit Volltextzugriff
(277)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(204)
Life Sciences & Biomedicine
(154)
Humans
(132)
Male
(77)
Female
(74)
Biological And Medical Sciences
(64)
Middle Aged
(62)
Hematology
(60)
Adult
(53)
Aged
(53)
Medical Sciences
(49)
Oncology
(46)
Physical Sciences
(32)
Hematologic And Hematopoietic Diseases
(26)
Aged, 80 And Over
(25)
Animals
(24)
Adolescent
(23)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(23)
Prognosis
(23)
Leukemia
(22)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Leukemia
(29)
Blood
(18)
Nature
(14)
Journal Of Applied Bacteriology
(12)
Leukemia Research
(10)
Leukemia & Lymphoma
(9)
Otology & Neurotology
(7)
Gene Therapy
(6)
La Revue De Medecine Interne
(6)
Annales Françaises D'anesthésie Et De Réanimation
(5)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias

Targeting MYC in multiple myeloma

Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms

RIP3 is downregulated in human myeloid leukemia cells and modulates apoptosis and caspase-mediated p65/RelA cleavage

Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML)

Copy-number analysis identified new prognostic marker in acute myeloid leukemia

Impact of Wilms' tumor 1 expression on outcome of patients undergoing allogeneic stem cell transplantation for AML

GATA2 gene mutations: 3 cases

Thoracic air bubbles of unusual cause

GILZ inhibits the mTORC2 AKT pathway in BCR-ABL cells

Molecular prognostic factors in acute myeloid leukemia receiving first-line therapy with azacitidine

Shortened First-Line High-Dose Chemotherapy for Patients With Poor-Prognosis Aggressive Lymphoma

Prognostic significance of monosomal karyotype in higher risk myelodysplastic syndrome treated with azacitidine

P851: TARGETING GENE DEPENDENCIES IN MYC OVEREXPRESSING MULTIPLE MYELOMA

Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy

Long-term follow up of invasive aspergillosis in allogeneic stem cell transplantation recipients and leukemia patients: Differences in risk factors and outcomes

P1257: MOLECULAR CHARACTERIZATION AND CLONAL EVOLUTION OF MYCOSIS FUNGOIDES

BCR-ABL mutants spread resistance to non-mutated cells through a paracrine mechanism

5LBA Results of a first-in-man phase I trial assessing OTX015, an orally available BET-bromodomain (BRD) inhibitor, in advanced hematologic malignancies

Effect of priming with granulocyte-macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group

High occurrence of JAK2 V617 mutation in refractory anemia with ringed sideroblasts associated with marked thrombocytosis

PO-264 Mitochondrial metabolism: a key factor of myeloid leukemic cell response upon exposure to tyrosine kinase inhibitors

Successful treatment of imatinib-resistant acute megakaryoblastic leukemia with e6a2 BCR ABL: use of dasatinib and reduced-conditioning stem-cell transplantation

Molecular characterization of the idiopathic hypereosinophilic syndrome (HES) in 35 French patients with normal conventional cytogenetics

Comment on “Experimental Observation of Electrons Accelerated in Vacuum to Relativistic Energies by a High-Intensity Laser”

Suchergebnisse filtern